Provided by Tiger Trade Technology Pte. Ltd.

Cellectis SA

1.25
-0.0900-6.72%
Post-market: 1.250.00000.00%16:10 EDT
Volume:106.83K
Turnover:134.28K
Market Cap:126.25M
PE:-1.93
High:1.31
Open:1.28
Low:1.22
Close:1.34
52wk High:5.48
52wk Low:1.22
Shares:101.00M
Float Shares:76.60M
Volume Ratio:1.47
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6479
EPS(LYR):-0.6740
ROE:-94.54%
ROA:-11.67%
PB:3.07
PE(LYR):-1.85

Loading ...

Cellectis Q1 Adj. EPS $(0.16) Beats $(0.27) Estimate, Sales $7.548M Miss $12.267M Estimate

Benzinga Earnings
·
May 12

Cellectis Reports Financial Results for the First Quarter 2026

GlobeNewswire
·
May 12

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
May 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Cellectis SA expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
May 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading

MT Newswires Live
·
May 06

Cellectis to Report First Quarter Financial Results on May 11, 2026

GlobeNewswire
·
May 05

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
May 04

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week

MT Newswires Live
·
May 01

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
Apr 29

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

GlobeNewswire
·
Apr 28

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live
·
Apr 24

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Apr 20

Cellectis Price Target Maintained With a $8.00/Share by Citizens

Dow Jones
·
Apr 14

Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments

TIPRANKS
·
Apr 14

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

GlobeNewswire
·
Apr 14

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13